Small Boost In Proposed NIH Budget Could Help Fund Electroceuticals Project
This article was originally published in The Gray Sheet
Executive Summary
The National Institutes of Health would see only a slight, less than one percent, increase over 2014 in its fiscal year 2015 budget under the president’s spending plan, but part of the increase could advance so-called electroceuticals research, NIH Director Francis Collins explained.
You may also be interested in...
With Academic Funding, GSK Looks to Zap Life Into Electroceuticals
By seeding exploratory lab work across several biomedical and engineering disciplines, pharma giant GlaxoSmithKline wants to understand how neural signals regulate diseases and eventually to design devices that can alter signals and provide therapeutic benefit.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip